A comprehensive view of neurological / cognitive health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
F. Hoffmann-La Roche Ltd. advances Alzheimer's research and champions early cancer detection; company schedules cancer detection conference on Oct 1 in Lisbon
Published:
July 26, 2024
by Industry Intelligence Inc.
|
Biogen Inc. advances Alzheimer's research and Rare Disease Awareness; company also promotes gender equality in STEM and shares stories of patients like Hannah with Friedreich's Ataxia
Published:
July 26, 2024
by Industry Intelligence Inc.
|
Eisai and Biogen disappointed by EMA's negative opinion on lecanemab for early Alzheimer's; the humanized anti-amyloid-beta monoclonal antibody was under review for mild cognitive impairment
Published:
July 26, 2024
by Biogen Inc.
|
Biogen Inc. supports neurological disorder initiatives showcasing patient resilience; programs include SMA patient Kim's journey and MS Motion tailored for those with multiple sclerosis
Published:
July 24, 2024
by Industry Intelligence Inc.
|
Amgen Inc. advances personalized medicine and patient-centered care; emphasizes pharmacogenetics, customizes treatments to enhance efficacy and reduce adverse effects
Published:
July 24, 2024
by Industry Intelligence Inc.
|
Ask us about our Consumer Wellness market view